|
WASF2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.638800E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.156300E-02 |
| Normal-vs-Stage2 |
6.662100E-03 |
| Normal-vs-Stage3 |
3.477900E-03 |
| Normal-vs-Stage4 |
6.869600E-02 |
| Stage1-vs-Stage2 |
3.839200E-01 |
| Stage1-vs-Stage3 |
4.756800E-01 |
| Stage1-vs-Stage4 |
6.613000E-01 |
| Stage2-vs-Stage3 |
7.409400E-01 |
| Stage2-vs-Stage4 |
2.809800E-01 |
| Stage3-vs-Stage4 |
3.467000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.338200E-03 |
| Normal-vs-AfricanAmerican |
3.936400E-01 |
| Normal-vs-Asian |
2.629400E-01 |
| Caucasian-vs-AfricanAmerican |
2.872600E-01 |
| Caucasian-vs-Asian |
6.178300E-02 |
| AfricanAmerican-vs-Asian |
9.644600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.032400E-02 |
| Normal-vs-Female |
3.183100E-03 |
| Male-vs-Female |
4.706400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.842100E-02 |
| Normal-vs-Age(41-60Yrs) |
9.038800E-03 |
| Normal-vs-Age(61-80Yrs) |
4.038100E-04 |
| Normal-vs-Age(81-100Yrs) |
4.162500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.877400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.341800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.785400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.325030E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.543200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.551400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.110400E-01 |
| Classical-VS-Follicular |
2.69819999998422E-06 |
| Classical-VS-Other |
4.749800E-01 |
| Classical-VS-Normal |
9.053700E-02 |
| Tall-VS-Follicular |
1.294010E-01 |
| Tall-VS-Other |
9.451600E-01 |
| Tall-VS-Normal |
2.405700E-02 |
| Follicular-VS-Other |
4.616000E-01 |
| Follicular-VS-Normal |
1.68108999999417E-05 |
| Other-VS-Normal |
1.832620E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.196600E-04 |
| Normal-vs-N1 |
6.583800E-04 |
| N0-vs-N1 |
4.855600E-01 |
|
|
